OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost-Effectiveness Analysis of Renin-Angiotensin Aldosterone System Blockade in Progression of Chronic Kidney Disease
Oraluck Pattanaprateep, Atiporn Ingsathit, Mark McEvoy, et al.
Value in Health Regional Issues (2018) Vol. 15, pp. 155-160
Open Access | Times Cited: 5
Oraluck Pattanaprateep, Atiporn Ingsathit, Mark McEvoy, et al.
Value in Health Regional Issues (2018) Vol. 15, pp. 155-160
Open Access | Times Cited: 5
Showing 5 citing articles:
Medical costs for managing chronic kidney disease and related complications in patients with chronic kidney disease and type 2 diabetes
Keith A. Betts, Jinlin Song, Elizabeth Faust, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 20, pp. S369-S374
Open Access | Times Cited: 17
Keith A. Betts, Jinlin Song, Elizabeth Faust, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 20, pp. S369-S374
Open Access | Times Cited: 17
FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes
Michał Pochopień, David Z.I. Cherney, Kerstin Folkerts, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 20, pp. S375-S382
Open Access | Times Cited: 9
Michał Pochopień, David Z.I. Cherney, Kerstin Folkerts, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 20, pp. S375-S382
Open Access | Times Cited: 9
ACE inhibitor or ARB treatment among patients with diabetes and chronic kidney disease
Linda F. Fried, Natalia Petruski‐Ivleva, Kerstin Folkerts, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 20, pp. S360-S368
Open Access | Times Cited: 8
Linda F. Fried, Natalia Petruski‐Ivleva, Kerstin Folkerts, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 20, pp. S360-S368
Open Access | Times Cited: 8
Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
Chaicharn Deerochanawong, Rungroj Krittayaphong, Jack Garcia Uranga Romano, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 3, pp. 531-552
Open Access | Times Cited: 1
Chaicharn Deerochanawong, Rungroj Krittayaphong, Jack Garcia Uranga Romano, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 3, pp. 531-552
Open Access | Times Cited: 1
An economic evaluation of pre-dialysis stage of chronic kidney disease
Elizaveta Rumiantseva, M. Avxentyeva
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (2021) Vol. 14, Iss. 3, pp. 365-378
Open Access | Times Cited: 2
Elizaveta Rumiantseva, M. Avxentyeva
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (2021) Vol. 14, Iss. 3, pp. 365-378
Open Access | Times Cited: 2
